Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Flare Therapeutics
Flare Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Flare Therapeutics
Total Funding
$82 M
Flare Therapeutics Summary
Company Summary
Overview
Flare Therapeutics is a company that provides precision oncology solutions. It develops molecule medicines for patients. The company offers precision therapies for cancer and other disorders by targeting transcription factors.
Type
Private
Status
Active
Founded
2021
HQ
Cambridge, MA, US
|
view all locations
Website
https://www.flaretx.com
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
oncology
therapy
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Robert Sims,
Chief Scientific Officer, Co-Founder
Aaron Davis,
Board Member
Jakob Loven,
Board Member
Steven M. Paul,
Board Member
and 3 others
Locations
View all
1 location detected
Cambridge, MA
HQ
United States
215 First Street, Suite 440
Competitors and Similar Companies
CureVac
Healthcare - Public
CytomX Therapeutics
Healthcare - Public
Astex Pharmaceuticals
Healthcare - Subsidiary
Gerot Lannach
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top